Redeem Book Code
You have no items in your shopping cart.
Redeem Book Code
RSSDI Diabetes Update 2020
RSSDI Diabetes Update 2020
Editors: Banshi Saboo, Ch Vasanth Kumar, Sanjay Agarwal
The current edition of RSSDI Diabetes Update 2020 comprises a wide range of topics extending from the basic anatomy and physiology of the islet, alterations in cell biology and functioning, and etiology and the text has been segregated into sections with related subtopics in each section to make it well organized and reader-friendly.
Epidemiology, pathogenesis, molecular mechanisms, entire spectrum of clinical aspects, controversies as well as research methodologies have been very well covered.
Divided into 19 sections having 102 chapters the book will enhance knowledge and has the potential to provide ideas for innovation and new research in the field.
The title includes chapters and updated guidelines with vast knowledge and skill base in the field of Diabetology.
Simple language and presentation enable this update to serve as a handy reference guide to not only diabetes physicians and endocrinologists, but also primary care practitioners, postgraduate students, and internists.
Flow diagrams, tables, and figures have been incorporated for better understanding and for practical use while understanding the topic.
Table of Contents
Buy as you go
Buy by the chapter and never pay more than the price of the full book.
Chapter 1: Life Expectancy in Diabetes: What does the Data Reveal?
Chapter 2: Role of Liver in Pathogenesis of Type 2 Diabetes Mellitus and Liver as a Target for Management
Chapter 3: Dysglycemia-based Chronic Disease and Metabolic Inflexibility: The Clinical Relevance
Chapter 4: Changing Landscape of Pediatric Diabetes in India
Chapter 5: New Clusters of Type 2 Diabetes Mellitus in Indians
Chapter 6: Pointers to Suspect Monogenic Diabetes in Clinical Practice
Chapter 7: Secondary Diabetes
Chapter 8: Fibrocalculous Pancreatic Diabetes/Malnutrition Related Diabetes Mellitus
Chapter 9: Prediabetes
Chapter 10: Metformin is the First-line Drug in People with Type 2 Diabetes Mellitus: Pros and Cons
Chapter 11: Alpha-glucosidase Inhibitors: Where Do We Place Them in Current Algorithm?
Chapter 12: Is there any Role of Hydroxychloroquine in Diabetes Management?
Chapter 13: Metformin: The Preferable First-line Option in Current Times of COVID-19
Chapter 14: Addressing Postprandial Glycemia with Glinides
Chapter 15: A Timely Step for Holistic Risk Modification in Type 2 Diabetes Mellitus Realizing Optimum Role of SGLT-2i + DPP-4i Combination
Chapter 16: Basal Insulin in Type 2 Diabetes Mellitus
Chapter 17: Quadruple Therapy versus Early Insulin Therapy: Why Early Insulin Therapy should be the Choice?
Chapter 18: Difficulties in Controlling Inpatient Hyperglycemia with Insulin Therapy
Chapter 19: Glucagon-like Peptide-1 Receptor Agonists
Chapter 20: The End of the Rainbow in Type 2 Diabetes Mellitus Management: Journey of GLP-1 Receptor Agonist from Concept to a Pen to a Pill
Chapter 21: Clinical Application of RSSDI Wheel
Chapter 22: Attaining Treatment Goals in T2DM: Managing Total Control with Simplicity and Convenience
Chapter 23: Multifactorial Management of Type 2 Diabetes Mellitus
Chapter 24: Should the Guidelines be Changed to Recommend Initial Combination Therapy in Adults Newly Diagnosed with Type 2 Diabetes Mellitus?
Chapter 25: Diabetes Care in Aging Population: Are Targets and Approach Same?
Chapter 26: Diabetes Management During Travel
Chapter 27: Perioperative Management of Diabetes: Is Insulin Therapy Only Solution?
Chapter 28: Diabetes, Prediabetes, and Cardiovascular Disease
Chapter 29: High Cardiovascular Risk and Chronic Kidney Disease: A Single Disease Spectrum
Chapter 30: Severe Hypoglycemia and Cardiovascular Events: A Complex Relationship
Chapter 31: Burden of Hypoglycemia in Adults with Diabetes Mellitus
Chapter 32: Managing Infections Specific to Diabetes
Chapter 33: Approach to a Patient with Diabetic Foot Ulcer
Chapter 34: Charcot Arthropathy, Charcot Foot, or Neuropathic Joint
Chapter 35: Painful Diabetic Neuropathy: Management Strategies
Chapter 36: Anemia in Diabetes
Chapter 37: Nondiabetic Renal Diseases in Patients with Diabetes Mellitus with Albuminuria
Chapter 38: Managing Infections Specific to Diabetes Mellitus
Chapter 39: Diabetes and Hyperuricemia
Chapter 40: Cognitive Decline in Diabetes
Chapter 41: Diabetes and Depression
Chapter 42: Diabetes Mellitus: Genitourinary Infections
Chapter 43: Diabetes Mellitus and Tuberculosis: Impact on Incidence, Treatment, and Outcomes
Chapter 44: Heart Failure in Diabetes Mellitus: Clinical Presentation and Diagnosis
Chapter 45: Type 2 Diabetes Mellitus and Heart Failure
Chapter 46: Diabetes and Gastrointestinal Complications
Chapter 47: Type 2 Diabetes Mellitus and Obstructive Sleep Apnea: An Update
Chapter 48: Window of Opportunity for Prevention of Cardiometabolic Disorders
Chapter 49: Gaps in the Management of Diabetes
Chapter 50: Metformin Controversies: A Review
Chapter 51: Diabetes Self-management Education and Support: Concept and Components
Chapter 52: Brief Motivational Strategies for the Busy Healthcare Provider
Chapter 53: Exercise in Obesity: Which? When? Why?
Chapter 54: Five Evidence-based Lifestyle Habits People with Diabetes can Use
Chapter 55: Insulin Distress and Insulin Motivation
Chapter 56: Time to Overcome Multifactorial Therapeutic Inertia
Chapter 57: Closing The Loop: How Close are We?
Chapter 58: Reducing the Risk of Developing Type 2 Diabetes Mellitus: The Future is Digital
Chapter 59: Insulin Delivery Today and in Future: Opportunities and Challenges
Chapter 60: Telemedicine Guidelines: Do's and Dont's in Diabetes Practice
Chapter 61: Use of Artificial Intelligence for Diabetes Management
Chapter 62: Social Media in Diabetes Management
Chapter 63: CardioMetabolic-Based Chronic Disease: A New Framework for Early and Sustainable Preventive Care
Chapter 64: Diabetes Mellitus and Vaccination
Chapter 65: Preventing Clinical Inertia: The Only Way a Dream of "Diabetes Complications Free India" Can Come True
Chapter 66: Diabetes Risk Score: Clinical Implication
Chapter 67: Blue Index: The Diabetes Health Score
Chapter 68: How can We Modify the Risk Factors for Diabetes and Coronary Artery Disease in Indians?
Chapter 69: Methods of Data Collection and Advantages of Electronic Medical Records: Challenges and the Way Forward in India
Chapter 70: Important Tips on Diet: A Must for Practicing Clinicians
Chapter 71: Carbohydrates in Indian Context: Quantity or Quality or Both?
Chapter 72: How to Meet Protein Requirement in Vegans
Chapter 73: Meal Replacement Therapy in Obesity and Diabetes Mellitus
Chapter 74: Keto Diets and Diabetes Reversal: Can Keto Diet Really Cure Diabetes?
Chapter 75: Intermittent Fasting: How to Use for a Person with Diabetes
Chapter 76: Tips for Successful Use of Blood Glucose Monitoring
Chapter 77: Glucovigilance
Chapter 78: Time-in-Range: Clinical Implications and Comparing Gen. 2.0 Basals
Chapter 79: Continuous Glucose Monitoring: The New Tool in Management of Diabetes
Chapter 80: Self-monitoring of Blood Glucose and Remote Monitoring in Diabetes Management
Chapter 81: Managing Diabetes: Think Beyond Glycemia (HbA1c)
Chapter 82: Evidence-based Nutrition for Gestational Diabetes
Chapter 83: Gestational Diabetes Mellitus Management: Oral Drugs and Monitoring
Chapter 84: Metformin in Pregnancy: Current Views
Chapter 85: A Study of the Prevalence of Autoantibodies in T1DM
Chapter 86: Top Ten Papers at EASD
Chapter 87: Top Ten Papers of International Journal of Diabetes in Developing Countries
Chapter 88: Diabetes Management: Learning from UKPDS and DCCT
Chapter 89: EMPA-REG/CANVAS/DECLARE-TIMI
Chapter 90: CREDENCE/DAPA-CKD
Chapter 91: Trials—ACCORD/ADVANCE/VADT
Chapter 92: Diabetes and Disasters: Do We Require Better Planning?
Chapter 93: Diabetes Mellitus and Sports
Chapter 94: Living and Loving with Erectile Dysfunction (ED=ED=ED) Erectile Dysfunction=Endothelial Dysfunction=Emotional Disturbance
Chapter 95: Psychosocial Aspects of Diabetes
Chapter 96: Rheumatological Manifestations of Diabetes Mellitus
Chapter 97: Diabetes and Autoimmune Disorders
Chapter 98: Dermatological Manifestations of Diabetes Mellitus
Chapter 99: Blood Pressure Goal: Do We Really Achieve
Chapter 100: ABPM versus HBPM versus Office BP: Which, When, Why?
Chapter 101: Blood Pressure Variability in Diabetes: Its Role in Development of Diabetes Complications
Chapter 102: Erectile Dysfunction in Diabetes Mellitus
Copyright © 2022 Jaypee Brothers Medical Publishers (P) Ltd. All rights reserved.